The retinoblastoma-like protein RBL2, a key factor in cell cycle regulation and apoptosis, was lately identified as a direct substrate of the AKT kinase which is known as a key antiapoptotic factor that is hyperactive in multiple cancer types. This evidence concerns the gene RBL2 and cancer.